TELA Bio, Inc. (TELA)
After hours:
| Previous close | 6.36 |
| Open | 6.37 |
| Bid | 6.27 x 300 |
| Ask | 6.34 x 100 |
| Day's range | 6.24 - 6.48 |
| 52-week range | 4.24 - 11.26 |
| Volume | |
| Avg. volume | 162,482 |
| Market cap | 154.836M |
| Beta (5Y monthly) | 1.00 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.64 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 14.20 |
Insider MonkeyTELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript
TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript May 11, 2024 TELA Bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio First Quarter 2024 Earnings Conference Call. […]
Simply Wall St.TELA Bio First Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.63 loss in 1Q 2023)
TELA Bio ( NASDAQ:TELA ) First Quarter 2024 Results Key Financial Results Revenue: US$16.6m (up 39% from 1Q 2023). Net...
GlobeNewswireTELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 20,250 shares of its common stock to eleven newly-hired employees, with a grant date of May 6, 2024 (the "Grant Date"). The restricted stock unit
